advanced search

Welcome: Guest

log in

Who's Developing What in Drug Delivery?

Publication Date October 2008
Publisher Espicom
Product Type Report
Pages 680
ISBN Number 978-1-85822-331-5
Product Code ESP00452
Price

£595.00
approximately: $910 | €663

PDFBuy Now
Order above formats by FAXOrder by FAX

Summary

The indispensible 2-volume guide to the companies that are shaping this critical area.

The importance of drug delivery technology grows ever more acute and commercial, and industry interest is continuing to build. The benefits to patients can be seen through improved medical outcomes, while the pharmaceutical industry is able to bring new products to market and extend patent protection through novel delivery regimes, and bring new therapies to the market that would previously have been impossible. Consequently, the drug delivery sector has evolved from being simply a part of the pharmaceutical production process to a driving force for innovation and profits. As a result, developers of drug delivery products and technology have benefited from significant attention from customers and investors alike, and merger and acquisition activity is notable. Whos Developing What in Drug Delivery? is a new 680+ page management report (expanded 4th edition, published October 2008) that provides comprehensive analysis of 135 leading players in the drug delivery field. By 2015 sales of products using advanced drug delivery technology assessed could exceed US$43 billion.

Key features and benefits...

  • Detailed review of 134 leading companies in the field
  • Comprehensive coverage of each companys technology focus, products, R&D and deals
  • International coverage companies from across the world reviewed

All major drug-delivery technologies covered including:

  • Controlled-release
  • Nucleic acid
  • Nano-enabled
  • Targeted

Content

  • 3M DRUG DELIVERY SYSTEMS
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • COMPETITION
  • ABRAXIS BIOSCIENCE INC
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH STRATEGY
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • RELATED COMPANIES
  • ACCESS PHARMACEUTICALS INC
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • COMPETITION
  • ACUSPHERE INC
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • COMPETITION
  • ACRUX LTD
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • AKELA PHARMA
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
  • R&D ACTIVITIES
  • TECHNOLOGIES/ PRODUCTS
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • ALIZYME PLC
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • COMPETITION
  • ALKERMES INC
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • COMPETITION
  • ALPHARX INC
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • ASSOCIATED COMPANIES
    • COMPETITION
  • ALPHAVAX INC
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • ALTEA THERAPEUTICS
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • ALZA CORPORATION
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • ANTARES PHARMA INC
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • COMPETITION
  • AP PHARMA INC
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • COMPETITION
  • ARADIGM CORPORATION
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • COMPETITION
  • AVIDIMER THERAPEUTICS INC
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • KEY FINANCIAL DATA
  • BAXA CORPORATION
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • BAXTER INTERNATIONAL INC
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • COMPETITION
  • BIODELIVERY SCIENCES INTERNATIONAL
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • KEY FINANCIAL DATA
    • ASSOCIATED COMPANIES
    • COMPETITION
  • BIOJECT MEDICAL TECHNOLOGIES INC
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • COMPETITION
  • BIOSANTE PHARMACEUTICALS INC
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • COMPETITION
  • BIOVAIL CORPORATION
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • ASSOCIATED COMPANIES
    • COMPETITION
  • CALANDO PHARMACEUTICALS
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • CAMURUS AB
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • CARDINAL HEALTH
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • COMPETITION
  • CELL THERAPEUTICS INC
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • CEPHALON
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS
    • R&D ACTIVITIES
    • AGREEMENTS
    • CIMA agreements
    • KEY FINANCIAL DATA
    • KEY COMPETITORS
  • CIPHER PHARMACEUTICALS
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • TECHNOLOGIES/ PRODUCTS
    • R&D MILESTONES
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • COLUMBIA LABORATORIES INC
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • COMPETITION
  • CONSORT MEDICAL PLC
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • COMPETITION
  • COPERNICUS THERAPEUTICS
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH STRATEGY
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • CPEX PHARMACEUTICALS INC
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • COMPETITION
  • CRITICAL THERAPEUTICS INC
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • CYDEX PHARMACEUTICALS
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • DEBIOPHARM SA
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • ASSOCIATED COMPANIES
  • DELCATH SYSTEMS INC
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • COMPETITION
  • DELSITE BIOTECHNOLOGIES INC
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • DEPOMED INC
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • COMPETITION
  • DIATOS SA
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • ASSOCIATED COMPANIES
  • DOR BIOPHARMA INC
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • COMPETITION
  • DURECT CORPORATION
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • ASSOCIATED COMPANIES
    • COMPETITION
  • DUSA PHARMACEUTICALS INC
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • COMPETITION
  • ECHO THERAPEUTICS
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • COMPETITION
  • ELAN CORPORATION
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • ELITE PHARMACEUTICALS INC
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • COMPETITION
  • EMISPHERE TECHNOLOGIES INC
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • COMPETITION
  • ENCAP DRUG DELIVERY
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • ENDO PHARMACEUTICALS
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS/TECHNOLOGIES/
    • R&D MILESTONES
    • AGREEMENTS
    • KEY COMPETITORS
    • KEY FINANCIAL DATA
  • ENDOCYTE
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • ENDOVASC INC
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • ASSOCIATED COMPANIES
    • COMPETITION
  • ENZON INC
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • COMPETITION
  • ETHYPHARM S/A
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • EURAND
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • EXPRESSION GENETICS INC
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • KEY FINANCIAL DATA
  • FERTIN PHARMA A/S
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • R&D ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • FLAMEL TECHNOLOGIES INC
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • COMPETITION
  • FZIOMED INC
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • GENEREX BIOTECHNOLOGY CORPORATION
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • COMPETITION
  • GILEAD SCIENCES
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • GLYCOLOGIC LTD
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH STRATEGY
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • HOSPIRA
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • COMPETITION
  • 3M DRUG DELIVERY SYSTEMS
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • COMPETITION
  • ABRAXIS BIOSCIENCE INC
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH STRATEGY
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • RELATED COMPANIES
  • ACCESS PHARMACEUTICALS INC
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • COMPETITION
  • ACUSPHERE INC
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • COMPETITION
  • ACRUX LTD
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • AKELA PHARMA
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • R&D ACTIVITIES
    • TECHNOLOGIES/ PRODUCTS
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • ALIZYME PLC
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • COMPETITION
  • ALKERMES INC
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • COMPETITION
  • ALPHARX INC
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • ASSOCIATED COMPANIES
    • COMPETITION
  • ALPHAVAX INC
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • ALTEA THERAPEUTICS
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • ALZA CORPORATION
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • ANTARES PHARMA INC
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • COMPETITION
  • AP PHARMA INC
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • COMPETITION
  • ARADIGM CORPORATION
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • COMPETITION
  • AVIDIMER THERAPEUTICS INC
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • KEY FINANCIAL DATA
  • BAXA CORPORATION
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • BAXTER INTERNATIONAL INC
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • COMPETITION
  • BIODELIVERY SCIENCES INTERNATIONAL
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • KEY FINANCIAL DATA
    • ASSOCIATED COMPANIES
    • COMPETITION
  • BIOJECT MEDICAL TECHNOLOGIES INC
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • COMPETITION
  • BIOSANTE PHARMACEUTICALS INC
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • COMPETITION
  • BIOVAIL CORPORATION
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • ASSOCIATED COMPANIES
    • COMPETITION
  • CALANDO PHARMACEUTICALS
    • KEY PERSONNEL
    • COMPANY OVERVIEW
  • MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • CAMURUS AB
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • CARDINAL HEALTH
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • COMPETITION
  • CELL THERAPEUTICS INC
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • CEPHALON
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS
    • R&D ACTIVITIES
    • AGREEMENTS
    • CIMA agreements
    • KEY FINANCIAL DATA
    • KEY COMPETITORS
  • CIPHER PHARMACEUTICALS
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • TECHNOLOGIES/ PRODUCTS
    • R&D MILESTONES
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • COLUMBIA LABORATORIES INC
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • COMPETITION
  • CONSORT MEDICAL PLC
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • COMPETITION
  • COPERNICUS THERAPEUTICS
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH STRATEGY
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • CPEX PHARMACEUTICALS INC
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • COMPETITION
  • CRITICAL THERAPEUTICS INC
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • CYDEX PHARMACEUTICALS
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • DEBIOPHARM SA
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • ASSOCIATED COMPANIES
  • DELCATH SYSTEMS INC
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • COMPETITION
  • DELSITE BIOTECHNOLOGIES INC
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • DEPOMED INC
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • COMPETITION
  • DIATOS SA
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • ASSOCIATED COMPANIES
  • DOR BIOPHARMA INC
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • COMPETITION
  • DURECT CORPORATION
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • ASSOCIATED COMPANIES
    • COMPETITION
  • DUSA PHARMACEUTICALS INC
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • COMPETITION
  • ECHO THERAPEUTICS
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • COMPETITION
  • ELAN CORPORATION
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • ELITE PHARMACEUTICALS INC
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • COMPETITION
  • EMISPHERE TECHNOLOGIES INC
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • COMPETITION
  • ENCAP DRUG DELIVERY
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • ENDO PHARMACEUTICALS
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS/TECHNOLOGIES/
    • R&D MILESTONES
    • AGREEMENTS
    • KEY COMPETITORS
    • KEY FINANCIAL DATA
  • ENDOCYTE
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • ENDOVASC INC
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • ASSOCIATED COMPANIES
    • COMPETITION
  • ENZON INC
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • COMPETITION
  • ETHYPHARM S/A
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • EURAND
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • EXPRESSION GENETICS INC
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • KEY FINANCIAL DATA
  • FERTIN PHARMA A/S
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • R&D ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • FLAMEL TECHNOLOGIES INC
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • COMPETITION
  • FZIOMED INC
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • GENEREX BIOTECHNOLOGY CORPORATION
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • COMPETITION
  • GILEAD SCIENCES
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • GLYCOLOGIC LTD
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH STRATEGY
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • HOSPIRA
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • COMPETITION
  • ImaRx THERAPEUTICS
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • IMM UNOGEN
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • IMPAX LABORATORIES
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • COMPETITION
  • INDEVUS PHARMA CEUTICALS
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • INNOCOLL TECHNOLOGIES
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • INOVIO BIOMEDICAL
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • TECHNOLOGIES/ PRODUCTS
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • KEY COMPETITORS
  • INSITE VISION INC
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • COMPETITION
  • INTERCELL AG
    • KEY PERSONNEL
    • COMPANY OVERVIEW
  • INTERCELL KEY MILESTONES
  • IOMAI KEY MILESTONES
  • INTERCELL PRODUCTS / TECHNOLOGIES
  • INTERCELL RESEARCH ACTIVITIES
  • IOMAI RESEARCH ACTIVITIES
  • INTERCELL AGREEMENTS
  • IOMAI AGREEMENTS
    • KEY FINANCIAL DATA
    • COMPETITION
  • INTRANASAL THERAPEUTICS INC
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • KV PHARMA CEUTICAL COMPANY
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • ASSOCIATED COMPANIES
    • COMPETITION
  • LABOPHARM INC
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • ASSOCIATED COMPANIES
    • COMPETITION
  • LAVIPHARM GROUP
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • LIGHT SCIENCES CORPORATION
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • ASSOCIATED COMPANIES
  • MA CROCHEM CORPORATION
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • COMPETITION
  • MAX CYTE INC
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • MDRNA
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • COMPETITION
  • MEDIMM UNE INC
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • COMPETITION
  • MELDEX INTERNATIONAL PLC
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • COMPETITION
  • MILESTONE SCIENTIFIC
    • KEY PERSONNEL
    • COMPANY BACKGROUND
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • COMPETITION
  • MIRUS BIO CORPORATION
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH STRATEGY
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • MOOG MEDICAL DEVICES
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • NANOBIOTIX
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • NANOMA TERIALS TECHNOLOGY
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • NANOBIO CORPORATION
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • KEY FINANCIAL DATA
  • NANOBIOMA GNETICS
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH
    • KEY FINANCIAL DATA
  • NANOCARRIER
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • NANOTHERAPEUTICS INC
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • NANO INTERFACE TECHNOLOGY
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • KEY FINANCIAL DATA
  • NANO S BIOTECHNOLOGY
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • NANOTECHNOLOGY VICTORIA
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • NEKTAR THERAPEUTICS
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • ASSOCIATED COMPANIES
    • COMPETITION
  • NEOPHARM INC
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • PRODUCTS / TECHNOLOGIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • NEUROTECH
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • ASSOCIATED COMPANIES
  • NEXM ED INC
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • COMPETITION
  • NORWOOD ABBEY
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • ASSOCIATED COMPANIES
  • NOVADEL PHARMA
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • COMPETITION
  • NOVAGALI PHARMA
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • NOVAVAX
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • COMPETITION
  • NOVEN PHARMA CEUTICALS
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • ASSOCIATED COMPANIES
    • COMPETITION
  • NOVOSOM AG
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • OAKWOOD LABORATORIES LLC
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • OCTOPLUS
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • OREXO
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • COMPETITION
  • ORIEL THERAPEUTICS INC
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • OTSUKA PHARMA
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • PCI BIOTECH
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • PENWEST PHARMA CEUTICALS COMPANY
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • FINANCIALS
    • COMPETITION
  • PHOQUS GROUP PLC
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • PHOSPHAGENICS LIMITED
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • TECHNOLOGIES/ PRODUCTS
    • Drug Enhancement
    • R&D ACTIVITIES
    • AGREEMENTS
    • FINANCIALS
  • PHOTOCURE ASA
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • ASSOCIATED COMPANIES
  • POINT BIOMEDICAL CORPORATION
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • KEY FINANCIAL DATA
  • PROTHERICS
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • TECHNOLOGIES/ PRODUCTS
    • R&D MILESTONES
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • QLT
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • COMPETITION
  • QUEST PHARMA TECH
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • SCOLR PHARMA INC
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • COMPETITION
  • SEATTLE GENETICS
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • SILENCE THERAPEUTICS
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • SKINVISIBLE INC
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH STRATEGY
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • COMPETITION
  • SKYEPHARMA PLC
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • ASSOCIATED COMPANIES
    • COMPETITION
  • SPHERICS INC
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • STARPHARMA
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • SUPRATEK PHARMA INC
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • SYNTONIX PHARMA CEUTICALS INC
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • TEKMIRA PHARMA CEUTICALS CORPORATION
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • TELESSO TECHNOLOGIES
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • ASSOCIATED COMPANIES
  • TRANSPHARMA MEDICAL
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • URIGEN PHARMA CEUTICALS
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • ASSOCIATED COMPANIES
    • COMPETITION
  • VECTURA LTD
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • ASSOCIATED COMPANIES
  • VICAL
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • VIVUS INC
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
    • COMPETITION
  • ZOGENIX INC
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • KEY MILESTONES
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH ACTIVITIES
    • AGREEMENTS
    • KEY FINANCIAL DATA
  • ZOSANO PHARMA
    • KEY PERSONNEL
    • COMPANY OVERVIEW
    • PRODUCTS / TECHNOLOGIES
    • RESEARCH STRATEGY
    • KEY FINANCIAL DATA